Fosamax and ONJ (Osteonecrosis of the Jaw)

Fosamax is in a class of prescription drugs called bisphosphonates. Fosamax and other bisphosphonates are used by millions of people to help prevent and treat bone loss and osteoporosis. The use of Fosamax and other bisphosphonates has been linked to cases of a jaw bone disease known as ONJ, osteonecrosis of the jaw. 

Many people depend on a class of prescription medications called bisphosphonates to help prevent and treat bone loss and osteoporosis. Bisphosphonates commonly are marketed under the trade names Fosamax, Boniva, and Actonel.

Fosamax is the most popular of the bisphosphonates.  Since being approved by the FDA in 1995, Fosamax has been has been prescribed to millions of people.  Merck is the manufacturer of Fosamax. Merck also is maker of VIOXX, a pain medicine shown to cause heart attacks and strokes.    

The use of Fosamax and other bisphosphonates has been linked to cases of a jaw bone disease is called ONJ, which stands for “osteonecrosis of the jaw” (which literally means “bone death of the jaw”).  As its name implies, ONJ is characterized by jaw bone decay and also sometimes is called Jaw Death or Dead Jaw. Since 2001, there have been more than 2,400 reported cases of ONJ.

Get a Free, Confidential Fosomax ONJ Case Evaluation

Laws called "statutes of limitation" impose limits on the amount of time after a patient suffers an injury within which to file a lawsuit. If you or a loved one has suffered ONJ (osteonecrosis of the jaw) or other jaw condition, contact us today for a free, confidential Fosamax ONJ case evaluation.